X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (520) 520
Publication (51) 51
Book Review (44) 44
Conference Proceeding (30) 30
Dissertation (28) 28
Patent (22) 22
Book Chapter (7) 7
Book / eBook (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (272) 272
humans (203) 203
female (133) 133
male (125) 125
middle aged (83) 83
adult (82) 82
analysis (65) 65
aged (58) 58
surgery (53) 53
research (45) 45
risk factors (44) 44
article (40) 40
animals (38) 38
young adult (37) 37
care and treatment (35) 35
health aspects (34) 34
mortality (34) 34
abridged index medicus (31) 31
adolescent (30) 30
treatment outcome (29) 29
cardiac & cardiovascular systems (27) 27
diagnosis (27) 27
prospective studies (26) 26
urology & nephrology (26) 26
medicine & public health (25) 25
patients (25) 25
risk (25) 25
pharmacology & pharmacy (24) 24
cancer (23) 23
aged, 80 and over (22) 22
disease (22) 22
genetics (22) 22
medicine (22) 22
usage (22) 22
genetics & heredity (21) 21
mutation (21) 21
phenotype (21) 21
mice (20) 20
multidisciplinary sciences (20) 20
studies (20) 20
biochemistry & molecular biology (19) 19
pharmacokinetics (19) 19
biomarkers (18) 18
databases, factual (18) 18
metabolism (18) 18
oncology (18) 18
outcomes (18) 18
retrospective studies (18) 18
child, preschool (17) 17
management (17) 17
methods (17) 17
research article (17) 17
united-states (17) 17
complications (16) 16
engineering, electrical & electronic (16) 16
identification (16) 16
original (16) 16
public, environmental & occupational health (16) 16
radiology, nuclear medicine & medical imaging (16) 16
rats (16) 16
time factors (16) 16
clinical neurology (15) 15
cohort studies (15) 15
diabetes (15) 15
gastroenterology & hepatology (15) 15
science (15) 15
united states - epidemiology (15) 15
acute-renal-failure (14) 14
child (14) 14
epidemiology (14) 14
ophthalmology (14) 14
pharmacology (14) 14
physiological aspects (14) 14
prognosis (14) 14
proteins (14) 14
united states (14) 14
algorithms (13) 13
brain (13) 13
genetic aspects (13) 13
genomes (13) 13
hospitals (13) 13
therapy (13) 13
gastroenterology and hepatology (12) 12
gene expression (12) 12
hygiene (12) 12
kidney diseases (12) 12
nephrology (12) 12
patient outcomes (12) 12
basic electric elements (11) 11
cross-sectional studies (11) 11
electric solid state devices not otherwise provided for (11) 11
electricity (11) 11
exposure (11) 11
genomics (11) 11
human necessities (11) 11
infant (11) 11
medical or veterinary science (11) 11
prevalence (11) 11
review (11) 11
semiconductor devices (11) 11
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Heat and Mass Transfer, ISSN 0017-9310, 12/2018, Volume 127, pp. 927 - 947
Journal Article
Sexually Transmitted Diseases, ISSN 0148-5717, 09/2018, Volume 45, Issue 9, pp. e72 - e74
ABSTRACTUsing National Ambulatory Medical Care Survey data from 2006 to 2015, we estimated the proportions of young women tested for chlamydia who were... 
PELVIC-INFLAMMATORY-DISEASE | PREVENTION | INFECTIOUS DISEASES | INFECTION | SERVICES | GONORRHEA | Sexually transmitted diseases--STD | Sexually transmitted diseases | Infectious diseases | Chlamydia | Ambulatory health care | Young women | Medical services | Chlamydia trachomatis | Symptoms | Offices | Health care | Polls & surveys | Womens health | Medical tests | Urogenital system
Journal Article
Neurosurgery, ISSN 0148-396X, 10/2016, Volume 79, Issue 4, pp. E524 - E526
BACKGROUND:The authors reviewed published articles pertaining to the preoperative imaging evaluation of nonfunctioning pituitary adenomas (NFPAs) and... 
Preoperative | Nonfunctioning pituitary adenomas | MRI | Imaging
Journal Article
Neurosurgery, ISSN 0148-396X, 10/2016, Volume 79, Issue 4, pp. E541 - E543
BACKGROUND:Nonfunctioning pituitary adenomas (NFPAs) are the most frequent pituitary tumors. Due to the lack of hormonal hypersecretion, posttreatment... 
Postoperative | Endocrine | Nonfunctioning pituitary adenomas | Imaging
Journal Article
Clinical Pharmacology in Drug Development, ISSN 2160-763X, 07/2019, Volume 8, Issue 5, pp. 637 - 646
TAK‐117 (also known as MLN1117 or serabelisib) is an orally available inhibitor of phosphoinositide 3‐kinase alpha being developed for treatment of solid... 
relative bioavailability | effect of food | pH modulation | phosphoinositide 3‐kinase alpha inhibitor | TAK‐117 | phosphoinositide 3-kinase alpha inhibitor | TAK-117 | PI3K PATHWAY | PHARMACOLOGY & PHARMACY | ABSORPTION | Bioavailability
Journal Article
Sexually Transmitted Diseases, ISSN 0148-5717, 06/2017, Volume 44, Issue 11, pp. 685 - 690
Journal Article
American Journal of Hematology, ISSN 0361-8609, 04/2016, Volume 91, Issue 4, pp. 400 - 405
The PI3K/AKT/mTOR signaling pathways are frequently dysregulated in multiple human cancers, including multiple myeloma (MM), non‐Hodgkin lymphoma (NHL), and... 
MAMMALIAN TARGET | RAPAMYCIN | INTERNATIONAL WORKSHOP | MTOR INHIBITION | RESPONSE CRITERIA | EVEROLIMUS | KINASE | PATIENTS PTS | HEMATOLOGY | CANCER | PI3K INHIBITOR | Benzoxazoles - pharmacology | Recurrence | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Mechanistic Target of Rapamycin Complex 2 | Mechanistic Target of Rapamycin Complex 1 | Multiprotein Complexes - antagonists & inhibitors | TOR Serine-Threonine Kinases - antagonists & inhibitors | Multiple Myeloma - drug therapy | Neoplasm Grading | Waldenstrom Macroglobulinemia - drug therapy | Aged, 80 and over | Female | Antineoplastic Agents - pharmacology | Waldenstrom Macroglobulinemia - diagnosis | Lymphoma, Non-Hodgkin - drug therapy | Multiple Myeloma - diagnosis | Administration, Oral | Benzoxazoles - therapeutic use | Treatment Outcome | Pyrimidines - pharmacology | Retreatment | Maximum Tolerated Dose | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Aged | Protein Kinase Inhibitors - pharmacology | Drug Monitoring | Neoplasm Staging | Lymphoma, Non-Hodgkin - diagnosis | Medical research | Care and treatment | Relapse | Plasma physics | Multiple myeloma | Clinical trials | Medicine, Experimental | Lymphomas | Nausea | Diseases | TOR protein | Thrombocytopenia | Creatinine | Toxicity | Urticaria | Mucosa | Fatigue | AKT protein | Patients | Lymphoma | 1-Phosphatidylinositol 3-kinase | Stomatitis | Asthenia | Vomiting | Pharmacokinetics | Drug dosages | Hodgkin's disease | Neutropenia | Macroglobulinemia | Index Medicus
Journal Article
Journal of Adolescent Health, ISSN 1054-139X, 10/2017, Volume 61, Issue 4, pp. 440 - 445
Journal Article
Sexually Transmitted Diseases, ISSN 0148-5717, 03/2016, Volume 43, Issue 3, pp. 147 - 151
OBJECTIVETo estimate the percentage of young, sexually active Medicaid-insured women who were tested for chlamydia by age, race/ethnicity, and history of... 
PELVIC-INFLAMMATORY-DISEASE | UNITED-STATES | INFECTIOUS DISEASES | SEXUALLY-TRANSMITTED INFECTIONS | DISPARITIES | DISEASES TREATMENT GUIDELINES | TRACHOMATIS | HEALTH-CARE | GONORRHEA | Health Services Accessibility - statistics & numerical data | United States - epidemiology | Age Factors | Humans | Chlamydia Infections - diagnosis | Mass Screening - statistics & numerical data | Reproductive Health Services - statistics & numerical data | European Continental Ancestry Group - statistics & numerical data | Hispanic Americans - statistics & numerical data | Chlamydia Infections - epidemiology | Insurance Coverage - statistics & numerical data | Medicaid - statistics & numerical data | Young Adult | African Americans - statistics & numerical data | Adolescent | Preventive Health Services | Female | Women | Chlamydia infections | Chlamydia | Analysis | Sexual behavior | Medicaid | Medicine, Preventive | Health aspects | Preventive health services | Medical tests | Ethnicity | Diagnosis | Social aspects | Health care | Diagnostic testing | Sexually transmitted diseases--STD | Ethnic minorities | Sexual behaviour | Racial differences | Model testing | Logit models | Chlamydia trachomatis | Preventive health care | Medical diagnosis | Racial inequalities | Sexually transmitted diseases | Minorities | Ethnic groups | Race | Ethnic differences | Age | Health inequalities | Minority & ethnic groups | Screening | Womens health | Government programs | Young women | Preventive programmes | Diagnostic systems | Women's issues | Index Medicus
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 4/2011, Volume 50, Issue 4, pp. 253 - 265
Patients with type 2 diabetes mellitus often have impaired renal function or may have impaired hepatic function, which can pose significant safety and... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Research-and-development | Antihyperglycaemics, pharmacokinetics | Type-2-diabetes-mellitus | Diabetes-mellitus | Dipeptides, pharmacokinetics | Renal-impairment | Saxagliptin, pharmacokinetics | Haemodialysis | Liver-dysfunction | METFORMIN | THERAPY | CHRONIC LIVER-DISEASE | SAFETY | IMPROVES GLYCEMIC CONTROL | RISK | PHARMACOLOGY & PHARMACY | RANDOMIZED CONTROLLED-TRIAL | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Hepatic Insufficiency - urine | Dipeptides - pharmacokinetics | Humans | Middle Aged | Hypoglycemic Agents - analysis | Half-Life | Dipeptides - urine | Male | Metabolic Clearance Rate | Adamantane - urine | Adamantane - analysis | Adamantane - blood | Adult | Dipeptidyl-Peptidase IV Inhibitors - analysis | Female | Renal Insufficiency - blood | Hepatic Insufficiency - metabolism | Adamantane - pharmacokinetics | Adamantane - adverse effects | Adamantane - analogs & derivatives | Severity of Illness Index | Hypoglycemic Agents - pharmacokinetics | Dialysis Solutions - chemistry | Dipeptides - adverse effects | Dipeptides - analysis | Renal Insufficiency - metabolism | Renal Insufficiency - urine | Hepatic Insufficiency - blood | Kidney Failure, Chronic - metabolism | Kidney Failure, Chronic - therapy | Dipeptidyl-Peptidase IV Inhibitors - pharmacokinetics | Kidney Failure, Chronic - blood | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Dipeptides - blood | Renal Dialysis | Complications and side effects | Liver diseases | Physiological aspects | Dosage and administration | Research | Pharmacokinetics | Saxagliptin | Index Medicus
Journal Article
Journal Article
Journal Article
Therapeutic Drug Monitoring, ISSN 0163-4356, 02/2006, Volume 28, Issue 1, pp. 116 - 122
Journal Article